Associate Professor Davide Castagno

Back

Associate Professor Davide Castagno

University of Turin, Turin (Italy)

Member of:

Presentations Articles

Cardiac implantable electronic devices following orthotopic heart transplantation: insights on indications and outcomes from a single centre experience

Event: EHRA 2024

Topic: Treatment

Session: Devices: bradycardia 4

Access

Vascular access in cardiac implantable electronic devices: a systematic review and network meta-analysis.

Event: ESC Congress 2023

Topic: Device Complications and Lead Extraction

Session: Device complications and lead extraction

Access

Role of the implantable loop recorder in clinical practice: insights on indications, diagnostic yield and therapeutic implications from a single, high volume, tertiary care centre experience

Event: EHRA 2023

Topic: Invasive Diagnostic Methods

Session: ePoster session 29

Access

Use, indications and diagnostic yield of implantable loop recorder in clinical practice: a single, high volume, tertiary care centre experience.

Event: ESC Congress 2020

Topic: Diagnostic Methods

Session: Arrhythmias, General ePosters

Access

Trends in heart failure epidemiology between 2007 and 2016 in Piedmont, Italy: findings from the Epi-HF study

Event: Heart Failure 2019

Topic: Epidemiology, Prognosis, Outcome

Session: Chronic Heart Failure – Epidemiology, Prognosis, Outcome

Access

Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: long-term results and clinical outcomes.

Event: ESC Congress 2017

Topic: Catheter ablation

Session: Catheter ablation

Access

Cardiac resynchronization therapy optimization by pressure recording analytical method: feasibility, efficacy and correlation with electrocardiographic and echocardiographic methods

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT/ ICD / Surgery

Access

Impact of different left bundle branch definitions on cardiac resynchronization therapy response and clinical outcomes

Event: ESC Congress 2016

Topic: Electrocardiography

Session: Tools to reduce ventricular arrhythmic in cardiac resynchronisation therapy patients and miscellaneous

Access

Prognostic importance of heart rate, and effect of sacubitril/valsartan according to heart rate, in PARADIGM-HF

Event: HEART FAILURE 2016

Topic: Prognosis

Session: Prognosis

Access

ESC 365 is supported by

Explore sponsored resources

Associate Professor Davide Castagno Follow

Contributor content

Cardiac implantable electronic devices following orthotopic heart transplantation: insights on indications and outcomes from a single centre experience

Vascular access in cardiac implantable electronic devices: a systematic review and network meta-analysis.

Role of the implantable loop recorder in clinical practice: insights on indications, diagnostic yield and therapeutic implications from a single, high volume, tertiary care centre experience

Use, indications and diagnostic yield of implantable loop recorder in clinical practice: a single, high volume, tertiary care centre experience.

Trends in heart failure epidemiology between 2007 and 2016 in Piedmont, Italy: findings from the Epi-HF study

Transcatheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy: long-term results and clinical outcomes.

Cardiac resynchronization therapy optimization by pressure recording analytical method: feasibility, efficacy and correlation with electrocardiographic and echocardiographic methods

Impact of different left bundle branch definitions on cardiac resynchronization therapy response and clinical outcomes

Prognostic importance of heart rate, and effect of sacubitril/valsartan according to heart rate, in PARADIGM-HF

ESC 365 is supported by

Associate Professor Davide Castagno